Clinical Trial Update: Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of LGT209 in healthy volunteers and patients with hypercholesterolemia has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• LGT209

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypercholesterolemia | Phase 1 | Status: COMPLETED